BASF signed contract with the international pharmaceutical company Sandoz

On April 26, 2021 the BASF concern signed contract with the international pharmaceutical company Sandoz, subsidiary of Novartis Int AG, about investments in Kundl/Shaftenau's research and production campus to Austria. The agreement will allow BASF to strengthen presence in the market of enzymes and biotechnological products. The parties agreed not to disclose financial details of the transaction. "These investments once again show our commitment of the industry of enzymes and biotechnologies. The BASF concern strengthens the positions thanks to access to production sites of the partner in the cities of Kundl and Shaftenau, which...